{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:02:35Z","timestamp":1790337755931,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005946","name":"The Jackson Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vascn.2026.108430","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:02:17Z","timestamp":1780300937000},"page":"108430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations"],"prefix":"10.1016","volume":"140","author":[{"given":"Brian R.","family":"Berridge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajeesh K.","family":"Cherian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lainee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie K.","family":"DaSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Michael","family":"Foley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Bratcher-Petersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2026.108430_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105345","article-title":"Gaps and challenges in nonclinical assessments of pharmaceuticals: An FDA\/CDER perspective on considerations for development of new approach methodologies","volume":"139","author":"Avila","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2026.108430_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2021.107055","article-title":"Core battery safety pharmacology testing - an assessment of its utility in early drug development","volume":"109","author":"Baldrick","year":"2021","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108430_bb0015","article-title":"Validation framework for in vivo digital measures","volume":"6","author":"Baran","year":"2024","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2026.108430_bb0020","article-title":"Emerging role of translational digital biomarkers within home cage monitoring technologies in preclinical drug discovery and development","volume":"15","author":"Baran","year":"2021","journal-title":"Frontiers in Behavioral Neuroscience"},{"key":"10.1016\/j.vascn.2026.108430_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.569001","article-title":"Continuous, automated breathing rate and body motion monitoring of rats with paraquat-induced progressive lung injury","volume":"11","author":"Baran","year":"2020","journal-title":"Frontiers in Physiology"},{"issue":"7","key":"10.1016\/j.vascn.2026.108430_bb0030","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/gerona\/glab024","article-title":"Digital biomarkers enable automated, longitudinal monitoring in a mouse model of aging","volume":"76","author":"Baran","year":"2021","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.vascn.2026.108430_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2024.1377542","article-title":"Digitalization of toxicology: Improving preclinical to clinical translation","volume":"6","author":"Berridge","year":"2024","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2026.108430_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2020.106896","article-title":"Use of the Actiwatch-Mini(R) in dog safety studies as an early indicator for drug-induced behavioural changes","volume":"104","author":"Cools","year":"2020","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"15","key":"10.1016\/j.vascn.2026.108430_bb0045","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1111\/bph.15868","article-title":"Planning experiments: Updated guidance on experimental design and analysis and their reporting III","volume":"179","author":"Curtis","year":"2022","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/j.vascn.2026.108430_bb0050","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2217\/pme-2018-0044","article-title":"Wearables and the medical revolution","volume":"15","author":"Dunn","year":"2018","journal-title":"Per Med"},{"key":"10.1016\/j.vascn.2026.108430_bb0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41746-020-0260-4","article-title":"Verification, analytical validation, and clinical validation (V3): The foundation of determining fit-for-purpose for biometric monitoring technologies (BioMeTs)","volume":"3","author":"Goldsack","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.vascn.2026.108430_bb0060","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3389\/fnins.2020.00896","article-title":"A non-invasive digital biomarker for the detection of rest disturbances in the SOD1G93A mouse model of ALS","volume":"14","author":"Golini","year":"2020","journal-title":"Frontiers in Neuroscience"},{"issue":"Pt A","key":"10.1016\/j.vascn.2026.108430_bb0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2015.06.027","article-title":"Drug induced hypertension\u2014an unappreciated cause of secondary hypertension","volume":"763","author":"Grossman","year":"2015","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.vascn.2026.108430_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.vascn.2017.02.016","article-title":"GLP in safety pharmacology studies: Report card after 15years","volume":"87","author":"Guth","year":"2017","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"7","key":"10.1016\/j.vascn.2026.108430_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.crmeth.2023.100532","article-title":"A fully automated home cage for long-term continuous phenotyping of mouse cognition and behavior","volume":"3","author":"Ho","year":"2023","journal-title":"Cell Reports Methods"},{"issue":"7","key":"10.1016\/j.vascn.2026.108430_bb0080","article-title":"AI-driven wearable bioelectronics in digital healthcare","volume":"15","author":"Huang","year":"2025","journal-title":"Biosensors-Basel"},{"key":"10.1016\/j.vascn.2026.108430_bb0085","series-title":"International Conference for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)","article-title":"ICH S7A: Safety pharmacology studies for human pharmaceuticals, 8th November 2000","author":"ICH","year":"2000"},{"key":"10.1016\/j.vascn.2026.108430_bb0090","series-title":"American College of Toxicology 2025 annual meeting, Phoenix, AZ","article-title":"AI-based continuous video monitoring of canines for detection of abnormal\/adverse events in nonclinical safety studies (S0804)","author":"Kopljar","year":"2025"},{"key":"10.1016\/j.vascn.2026.108430_bb0095","series-title":"Drug discovery and evaluation: Safety and pharmacokinetic assays","first-page":"2257","article-title":"Maximum tolerated dose (MTD) studies in drug toxicology assessments","author":"Koshman","year":"2024"},{"issue":"1","key":"10.1016\/j.vascn.2026.108430_bb0100","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.vascn.2011.03.003","article-title":"Comparison of methods for the assessment of locomotor activity in rodent safety pharmacology studies","volume":"64","author":"Lynch","year":"2011","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108430_bb0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1489308","article-title":"Automated home cage monitoring of an aging colony of mice-implications for welfare monitoring and experimentation","volume":"18","author":"Moore","year":"2024","journal-title":"Frontiers in Neuroscience"},{"issue":"16","key":"10.1016\/j.vascn.2026.108430_bb0110","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1111\/bph.15193","article-title":"The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research","volume":"177","author":"Percie du Sert","year":"2020","journal-title":"British Journal of Pharmacology"},{"issue":"6","key":"10.1016\/j.vascn.2026.108430_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0280416","article-title":"Bouts of rest and physical activity in C57BL\/6J mice","volume":"18","author":"Pernold","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.vascn.2026.108430_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.vascn.2019.106591","article-title":"The functional observational battery and modified Irwin test as global neurobehavioral assessments in the rat: Pharmacological validation data and a comparison of methods","volume":"98","author":"Redfern","year":"2019","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"issue":"5","key":"10.1016\/j.vascn.2026.108430_bb0125","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/gerona\/glad035","article-title":"An automated, home-cage, video monitoring-based mouse frailty index detects age-associated morbidity in C57BL\/6 and diversity outbred mice","volume":"78","author":"Ruby","year":"2023","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1016\/j.vascn.2026.108430_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2025.1655330","article-title":"Rodent home cage monitoring for preclinical safety pharmacology assessment: Results of a multi-company validation evaluating nonclinical and clinical data from three compounds","volume":"7","author":"Sillito","year":"2025","journal-title":"Frontiers in Toxicology"},{"key":"10.1016\/j.vascn.2026.108430_bb0135","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2024.1456307","article-title":"Accurate locomotor activity profiles of group-housed mice derived from home cage monitoring data","volume":"18","author":"Sun","year":"2024","journal-title":"Frontiers in Neuroscience"},{"issue":"19","key":"10.1016\/j.vascn.2026.108430_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194798","article-title":"Activity in group-housed home cages of mice as a novel preclinical biomarker in oncology studies","volume":"15","author":"Terry","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"14","key":"10.1016\/j.vascn.2026.108430_bb0145","doi-asserted-by":"crossref","DOI":"10.3390\/ani15142025","article-title":"Physical activity monitors in companion animal chronic pain research-A review focused on osteoarthritis pain","volume":"15","author":"Thonen-Fleck","year":"2025","journal-title":"Animals"},{"issue":"Pt 1","key":"10.1016\/j.vascn.2026.108430_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2018.03.008","article-title":"Pharmacological validation of individual animal locomotion, temperature and behavioural analysis in group-housed rats using a novel automated home cage analysis system: A comparison with the modified Irwin test","volume":"94","author":"Tse","year":"2018","journal-title":"Journal of Pharmacological and Toxicological Methods"},{"key":"10.1016\/j.vascn.2026.108430_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105368","article-title":"2000-2023 over two decades of ICH S7A: Has the time come for a revamp?","volume":"139","author":"Valentin","year":"2023","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2026.108430_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105795","article-title":"Points to consider for revising the ICH S7A guideline on safety and secondary pharmacology","volume":"159","author":"Valentin","year":"2025","journal-title":"Regulatory Toxicology and Pharmacology"},{"issue":"9","key":"10.1016\/j.vascn.2026.108430_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257694","article-title":"Automated monitoring of respiratory rate as a novel humane endpoint: A refinement in mouse metastatic lung cancer models","volume":"16","author":"Winn","year":"2021","journal-title":"PLoS One"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871926000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T11:22:32Z","timestamp":1790335352000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871926000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":33,"alternative-id":["S1056871926000237"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108430","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-invasive, home cage digital monitoring for improved safety pharmacology assessments in drug development: ICH S7A update considerations","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2026.108430","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108430"}}